Association Between Sublingual Buprenorphine-Naloxone Exposure and Dental Disease.  Etminan M, Rezaeianzadeh R, Kezouh A, Aminzadeh K.  JAMA. 2022;328(22):2269–2271. doi:10.1001/jama.2022.17485 Abstract https://jamanetwork.com/jou…

Buprenorphine Maintenance in the Fentanyl Era: Challenges and Opportunities.  Modesto-Lowe V, Jain L.  Prim Care Companion CNS Disord. 2023 Feb 14;25(1):22l03336. doi: 10.4088/PCC.22l03336. PMID: 36821774. https://www.psychiatrist.com/p…

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021.  Del Pozo B, Atkins D, Andraka-Christou B, Wightman R, Clark MH, Huynh P, Ray B.  Drug Alcohol D…

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature.  Ordean A, Tubman-Broeren M.  Pathophysiology. 2023 Feb 11;30(1):27-36. doi: 10.3390/pathophysiology30010004. PMID: 36810423; PMCID: PMC99…

Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization.  Gu M, Li A, Mak W, Dong F, Xu N, Zhang J, Shi Y, Zheng N, Tan…

Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States.  Sun T, Katenka N, Kogut S, Bratberg J, Rich J, Buchanan A.  Pharmacoepidemiolog…